75 min/wk aerobic exercise for Colorectal Cancer

Kaiser Permanente Northern California, Oakland, CA
Colorectal CancerAerobic exercise - Behavioral
Eligibility
18+
All Sexes

Study Summary

This trial will measure how exercise affects cancer survivors' chemotherapy treatment and its effectiveness.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 12- or 24-weeks

12- or 24-weeks
Chemotherapy Relative Dose Intensity

Trial Safety

Trial Design

5 Treatment Groups

75 min/wk aerobic exercise
1 of 5
150 min/wk aerobic exercise
1 of 5
300 min/wk aerobic exercise
1 of 5
225 min/wk aerobic exercise
1 of 5
Attention control
1 of 5

Experimental Treatment

Non-Treatment Group

219 Total Participants · 5 Treatment Groups

Primary Treatment: 75 min/wk aerobic exercise · Has Placebo Group · N/A

75 min/wk aerobic exercise
Behavioral
Experimental Group · 1 Intervention: Aerobic exercise · Intervention Types: Behavioral
150 min/wk aerobic exercise
Behavioral
Experimental Group · 1 Intervention: Aerobic exercise · Intervention Types: Behavioral
300 min/wk aerobic exercise
Behavioral
Experimental Group · 1 Intervention: Aerobic exercise · Intervention Types: Behavioral
225 min/wk aerobic exercise
Behavioral
Experimental Group · 1 Intervention: Aerobic exercise · Intervention Types: Behavioral
Attention control
Behavioral
ShamComparator Group · 1 Intervention: Progressive stretching · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Aerobic exercise
2000
Completed Phase 2
~1080

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12- or 24-weeks

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,283 Previous Clinical Trials
41,235,179 Total Patients Enrolled
Pennington Biomedical Research CenterLead Sponsor
273 Previous Clinical Trials
177,170 Total Patients Enrolled
Jeffrey A. Meyerhardt, M.D., M.P.H.Principal InvestigatorDana-Farber Cancer Institute
Bette J. Caan, Dr.P.H.Principal InvestigatorKaiser Permanente
Justin C. Brown, Ph.D.Principal InvestigatorPennington Biomedical Research Center
1 Previous Clinical Trials
70 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there any openings for enrolment in this clinical investigation?

"Affirmative. Clinical trials.gov lists this clinical trial as being open for recruitment, having been first posted on May 1st 2023 and last updated on May 5th of the same year. A total of 219 patients are sought from 3 distinct sites." - Anonymous Online Contributor

Unverified Answer

How many participants have been recruited for this clinical investigation?

"Affirmative. According to the clinicaltrials.gov listing, this study is open for enrollment and has been since May 1st 2023 with its last update on May 5th 2023. 219 participants are needed between 3 different healthcare facilities." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.